Cybernet Data Systems Inc.
The company, a leading provider of software for infrastructure engineering, has outlined its financial performance and strategic direction. Founded in 1984, the company has consistently demonstrated growth, with revenues increasing by approximately 8% compound annual rate between 2000 and 2019. The company's initial public offering (IPO) was completed
Cybernet Data Systems Inc.
Pfizer Inc. is set to merge its Upjohn business with Mylan, a global pharmaceutical company, creating a new entity named Viatris. The transaction, which has been approved by Mylan shareholders, is expected to close on November 16, 2020. As part of the deal, Pfizer will contribute the Upjohn business to
Cybernet Data Systems Inc.
This prospectus supplement updates and amends information in the original prospectus supplement dated May 15, 2019, to reflect changes in the common stock offering. Notably, Truist Securities, Inc. has replaced BB&T Capital Markets as a sales agent, and J.P. Morgan Securities LLC has terminated its role as
Information technology services industry
The COVID-19 pandemic has thrown the world into chaos, disrupting businesses and industries in unprecedented ways. Optical retailers, like America's Best Contacts and Eyeglasses, have been no exception, forced to adapt to a rapidly changing environment. In this analysis, we delve into the financials and strategies employed by
Cybernet Data Systems Inc.
Urovant Sciences Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, announced its financial results for the second fiscal quarter ended September 30, 2020. The company achieved several significant operational and commercial planning milestones in preparation for the U.S. Food and Drug Administration&
Information technology services industry
PNM Resources, a New Mexico corporation, has entered into an Agreement and Plan of Merger with AVANGRID, a New York corporation, and NM Green Holdings, Inc., a New Mexico corporation and a wholly-owned subsidiary of AVANGRID. The merger, subject to customary closing conditions and approvals, will result in PNM Resources
Securities law
Herbalife Nutrition Ltd. has recently faced a securities law investigation due to its settlement with regulatory bodies over alleged bribery and corruption in its China operations. The company filed its quarterly report for the first quarter of 2020, revealing that it had reached an understanding with the SEC and DOJ
Securities law
Yum China Holdings, the largest restaurant company in China by system sales in 2019, has announced the launch of its Hong Kong public offering, which forms part of a global offering of 41,910,700 new shares of common stock. The offering includes an international offering of 40,234,200
United States. Securities and Exchange Commission
The Securities and Exchange Commission (SEC) has adopted final rules to modernize the accredited investor definition, expanding the definition to include individuals with special certifications. However, Rep. French Hill (R-AR) and other lawmakers have expressed disappointment that the new definition does not include professional experience, a key provision in the
United States. Securities and Exchange Commission
Herbalife Nutrition Ltd. has made headlines in recent weeks following its settlement with the U.S. Securities and Exchange Commission (SEC) and Department of Justice (DOJ) over alleged Foreign Corrupt Practices Act (FCPA) violations in its China operations. The Company reached an agreement with the SEC and DOJ, which included
Stock offerings
PDS Biotechnology Corporation, a clinical-stage immunotherapy company, has announced the pricing of a public offering of 6 million shares of common stock at a public offering price of $2.75 per share. This offering is expected to generate gross proceeds of $16.5 million for the company, which plans to
Stock offerings
PDS Biotechnology Corporation, a clinical-stage immunotherapy company, has announced plans to offer and sell shares of its common stock in an underwritten public offering. The company intends to use the proceeds from this offering to fund working capital and general corporate purposes. The proposed public offering is subject to market
